TCMD

TACTILE SYSTEMS TECHNOLOGY INC

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. MN · CIK 0001027838
$25.25 -0.59% $569.5M
Insider Selling Cluster (3 insiders)4 New Institutional Positions
Vol
Market Cap$569.5M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (91%)
Inst. Holders8 funds
Inst. Value$109.7M
Inst. Activity4 buys / 1 sells
Insider Activity0B / 7S
Insider Net $-$1.5M
SEC Reports3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. MN·CIK 0001027838·Prev Close $25.40

Recent Activity

May 20, 2026 other
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
<p align="justify">MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc.
May 11, 2026 Insider
Birkemeyer Elaine M. sold 4,631 shares
CHIEF FINANCIAL OFFICER @ $24.49 ($113.4K)
May 6, 2026 Insider
Huggenberger Raymond sold 6,521 shares
Director @ $0.00 ($0.00)
May 6, 2026 Insider
BURKE WILLIAM W sold 6,521 shares
Director @ $0.00 ($0.00)
Apr 20, 2026 SEC
Tactile Systems Technology (TCMD) issued a press release announcing the upcoming release of its Q1 FY2026 earnings on Ma
PRESS-RELEASE — Impact 3/10
Mar 25, 2026 SEC
Tactile Systems Technology, Inc. (TCMD) is holding its 2026 annual shareholder meeting to vote on four key items: the el
DEFA14A — Impact 3/10
Feb 26, 2026 SEC
Multiple executives at Tactile Systems Technology (TCMD) sold shares in the past week, including CEO Sheri Dodd and CFO
CLUSTER — Impact 4/10
Inst.
MORGAN STANLEY — TRIM
1,463,247 shares ($42.4M)

Price Targets

$39.50 +50.0% upside Strong Buy
Current $26.34 Low $36.00 Median $40.00 High $42.00 4 analysts
$36.00 $42.00

Analyst Ratings

Strong Buy91% buy · 11 analysts
4Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 21, 2026 BTIG REITERATE Buy → Buy
May 7, 2026 B. Riley Securities UPGRADE Neutral → Buy
May 5, 2026 BTIG MAINTAIN Buy → Buy
Feb 18, 2026 B. Riley Securities MAINTAIN Neutral → Neutral
Feb 18, 2026 Piper Sandler MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.17 ▲ +3.0% $0.16 — $0.18 21% YoY 2
Next Q $0.39 ▲ +1.3% $0.37 — $0.41 8% YoY 2
Current FY $1.09 ▼ -1.4% $1.05 — $1.14 32% YoY 2
Next FY $1.50 ▲ +2.0% $1.35 — $1.66 37% YoY 2

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$47.9M
MORGAN STANLEY$42.4MTRIM
RENAISSANCE TECHNOLOGIES LLC$11.2MADD
FMR LLC$3.1MADD
BANK OF AMERICA CORP$2.0MADD

Recent Insider Trades

DateInsiderTypeValue
May 11, 2026Birkemeyer ElaineSELL$113.4K
May 6, 2026Huggenberger RaymondA$0.00
May 6, 2026BURKE WILLIAMA$0.00
May 6, 2026Washington BoydA$0.00
May 6, 2026Volkart CarmenA$0.00
8 institutional holders with $109.7M total value (3,783,390 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, RENAISSANCE. Net buying activity: 4 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC1,651,170$47.9M43.6%
2MORGAN STANLEY1,463,247$42.4M38.7%TRIM -36.2%
3RENAISSANCE TECHNOLOGIES LLC386,300$11.2M10.2%ADD +44.0%
4FMR LLC105,882$3.1M2.8%ADD +25.3%
5BANK OF AMERICA CORP /DE/67,802$2.0M1.8%ADD +48.8%
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC65,447$1.9M1.7%TRIM -40.6%
7WELLS FARGO & COMPANY/MN27,022$783.6K0.7%ADD +35.7%
8TWO SIGMA INVESTMENTS, LP16,520$479.1K0.4%NEW

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYTRIM2,293,1201,463,247-36.2%$42.4M2025-Q4
FMR LLCADD84,527105,882+25.3%$3.1M2025-Q4
BANK OF AMERICA CORP /DE/ADD45,56067,802+48.8%$2.0M2025-Q4
WELLS FARGO & COMPANY/MNADD19,91727,022+35.7%$783.6K2025-Q4
TWO SIGMA INVESTMENTS, LPNEW16,520$479.1K2025-Q4
BANK OF AMERICA CORP /DE/ADD32,24945,560+41.3%$630.6K2025-Q3
NORGES BANKEXIT144,4000-100.0%$0.002025-Q3
TWO SIGMA INVESTMENTS, LPEXIT12,0220-100.0%$0.002025-Q3
UBS Group AGADD177,607334,863+88.5%$3.4M2025-Q2
NORGES BANKNEW144,400$1.5M2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM99,17558,902-40.6%$597.3K2025-Q2
BANK OF AMERICA CORP /DE/TRIM50,54932,249-36.2%$327.0K2025-Q2
TWO SIGMA INVESTMENTS, LPNEAR_EXIT59,27812,022-79.7%$121.9K2025-Q2
UBS Group AGDOUBLED41,445177,607+328.5%$2.3M2025-Q1
TWO SIGMA INVESTMENTS, LPADD36,09459,278+64.2%$783.7K2025-Q1
NORGES BANKEXIT147,9000-100.0%$0.002025-Q1
RENAISSANCE TECHNOLOGIES LLCADD313,200451,100+44.0%$7.7M2024-Q4
CITADEL ADVISORS LLCDOUBLED15,735104,596+564.7%$1.8M2024-Q4
UBS Group AGDOUBLED8,63741,445+379.9%$710.0K2024-Q4
WELLS FARGO & COMPANY/MNADD12,94416,719+29.2%$286.4K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW127,175$1.9M2024-Q3
11 unique insiders with 7 transactions. Net insider value: -$1.5M ($0.00 bought, $1.5M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 11, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSELL4,631$24.49$113.4K
May 6, 2026Huggenberger RaymondDirectorA6,521$0.00$0.00
May 6, 2026BURKE WILLIAM WDirectorA6,521$0.00$0.00
May 6, 2026Washington Boyd VindellDirectorA6,521$0.00$0.00
May 6, 2026Volkart Carmen BDirectorA6,521$0.00$0.00
May 6, 2026Shafer David BrentDirectorA6,521$0.00$0.00
May 6, 2026Pearson AndreaDirectorA6,521$0.00$0.00
May 6, 2026King Laura G.DirectorA6,521$0.00$0.00
May 6, 2026Asbury Valerie L.DirectorA6,521$0.00$0.00
Mar 9, 2026Pearson AndreaDirectorA852$0.00$0.00
Feb 24, 2026Burns KristieSr. VP Mktg & Clinical AffairsSELL6,246$28.94$180.8K
Feb 24, 2026Dodd Sheri LouiseChief Executive OfficerSELL10,993$28.94$318.1K
Feb 24, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSELL7,701$28.94$222.9K
Feb 23, 2026Burns KristieSr. VP Mktg & Clinical AffairsSELL4,279$28.28$121.0K
Feb 23, 2026Dodd Sheri LouiseChief Executive OfficerSELL14,703$28.28$415.8K
Feb 23, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSELL5,322$28.28$150.5K
Feb 20, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERA3,579$0.00$0.00
Feb 20, 2026Burns KristieSr. VP Mktg & Clinical AffairsA3,490$0.00$0.00
Feb 20, 2026Dodd Sheri LouiseChief Executive OfficerA19,751$0.00$0.00
Feb 19, 2026Burns KristieSr. VP Mktg & Clinical AffairsA6,194$0.00$0.00
Feb 19, 2026Dodd Sheri LouiseChief Executive OfficerA48,672$0.00$0.00
Feb 19, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERA23,008$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (91% buy). Based on 11 analysts: 4 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$39.50 mean target +50.0% upside Strong Buy (1.20)
$36.00 Low $42.00 High
MetricValue
Current Price$26.34
Target Low$36.00
Target Mean$39.50
Target Median$40.00
Target High$42.00
# Analysts4
RecommendationStrong Buy (1.20)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.17 $0.16 $0.18 21.4% +3.0% 1↑ 0↓ $0.1B 8.4% 2
Next Q
2026-09-30
$0.39 $0.37 $0.41 8.3% +1.3% 1↑ 0↓ $0.1B 9.1% 2
Current FY
2026-12-31
$1.09 $1.05 $1.14 31.6% -1.4% 1↑ 1↓ $0.4B 10.7% 2
Next FY
2027-12-31
$1.50 $1.35 $1.66 37.4% +2.0% 2↑ 0↓ $0.4B 9.0% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.170
7d ago$0.170
30d ago$0.165+0.005
60d ago$0.165+0.005
90d ago$0.165+0.005
3 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 21, 2026 BTIG REITERATE Buy Buy
May 7, 2026 B. Riley Securities UPGRADE Neutral Buy
May 5, 2026 BTIG MAINTAIN Buy Buy
Feb 18, 2026 B. Riley Securities MAINTAIN Neutral Neutral
Feb 18, 2026 Piper Sandler MAINTAIN Overweight Overweight
Feb 18, 2026 BTIG MAINTAIN Buy Buy
Jan 5, 2026 Piper Sandler UPGRADE Neutral Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264610091%
May 1, 20264520082%
Apr 1, 20264520082%
Mar 1, 20264520082%
Feb 1, 20264520082%
Jan 1, 20264430073%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 20, 2026
other
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
<p align="justify">MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD),
May 4, 2026
earnings
Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
<p align="justify">MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD),
May 4, 2026
earnings_calendar
TCMD Q1 2026 Earnings Scheduled — 2026-05-04
Apr 20, 2026
earnings
Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026
<p align="justify">MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD
Mar 9, 2026
other
Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
<p align="justify">MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD